Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Reneo Pharmaceuticals (RPHM)
NASDAQ:RPHM
RESEARCH TOOLSreports
Reneo Pharmaceuticals (RPHM) Stock Forecast & Price Target
222 Followers
See the Price Targets and Ratings of:
RPHM Analyst Ratings
Moderate Sell
0 Buy
1 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RPHM Stock 12 Month Forecast
Average Price Target
$1.10
▼(-37.50% Downside)
| Highest Price Target$1.20 | Average Price Target$1.10 | Lowest Price Target$1.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
03/28/24
Leerink Partners
Reiterated
03/28/24
Jefferies
$1.80
Hold
2.27%
Upside
Downgraded
12/15/23
Reneo Pharmaceuticals just downgraded at Jefferies, here's whyReneo Pharmaceuticals just downgraded at Jefferies, here's why
H.C. Wainwright
$1.50
Hold
-14.77%
Downside
Downgraded
12/15/23
Hold Rating on Reneo Pharmaceuticals Following Lead Drug Trial Failure and Strategic Uncertainty
Ladenburg Thalmann & Co.
―
Hold
―
Downgraded
12/14/23
Reneo Pharmaceuticals just downgraded at Ladenburg, here's whyReneo Pharmaceuticals just downgraded at Ladenburg, here's why
Piper Sandler
$4.00
Hold
127.27%
Upside
Downgraded
12/14/23
Piper Sandler downgrades Reneo Pharmaceuticals (RPHM) to NeutralPiper Sandler analyst Yasmeen Rahimi downgraded Reneo Pharmaceuticals (NASDAQ: RPHM) from Overweight to Neutral with a price target of $4.00 (from $25.00).
Robert W. Baird
$3.00
Hold
70.45%
Upside
Downgraded
12/14/23
Analysts Offer Insights on Healthcare Companies: Rain Therapeutics (NASDAQ: RAIN), Reneo Pharmaceuticals (NASDAQ: RPHM) and Bicycle Therapeutics (NASDAQ: BCYC)
Best Analysts Covering Reneo Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy RPHM and Sell After:
1 Month
3 Months
1 Year
Success Rate
0/4 ratings generated profit
Average Return
-50.30%
reiterated a sell rating 29 days ago
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -50.30% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RPHM Analyst Recommendation Trends
Rating
Sep 23
Oct 23
Nov 23
Dec 23
Mar 24
Strong Buy
4
8
9
8
3
Buy
0
1
1
1
0
Hold
0
0
0
8
9
Sell
0
0
0
1
2
Strong Sell
0
0
0
0
0
total
4
9
10
18
14
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
RPHM Financial Forecast
RPHM Stock Forecast FAQ
What is RPHM’s average 12-month price target, according to analysts?
Based on analyst ratings, Reneo Pharmaceuticals’s 12-month average price target is $1.10.
What is RPHM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for RPHM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RPHM a Buy, Sell or Hold?
Reneo Pharmaceuticals has a conensus rating of Moderate Sell which is based on 0 buy ratings, 1 hold ratings and 1 sell ratings.
What is Reneo Pharmaceuticals’s price target?
The average price target for Reneo Pharmaceuticals is $1.10. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.20 ,the lowest forecast is $1.00. The average price target represents -37.50% Decrease from the current price of $1.76.
The highest analyst price target is $1.20 ,the lowest forecast is $1.00. The average price target represents -37.50% Decrease from the current price of $1.76.
What do analysts say about Reneo Pharmaceuticals?
Reneo Pharmaceuticals’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of RPHM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.